Current Research Studies

Cancer – ACCL1033: A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL

Condition or Therapy:

Acute Lymphoblastic Leukemia (ALL)


Cancer and Blood Disorders
Study Number: ACCL1033

What is the goal of this study?

This study is comparing if patients with ALL take their medication better if they are exposed to a multi-component intervention rather than just an educational video.

Who can join the study?

This study may be a good fit for children and young adults who:

  • are 1 to 21 years old, and
  • have been diagnosed with acute lymphoblastic leukemia.

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Eric Chow